Skip to main content
Premium Trial:

Request an Annual Quote

David Gorin, Robert Sprung

Premium
This week the Canary Foundation and American Cancer Society Early Detection Postdoctoral Fellowship Program for 2008 gave five recipients $138,000 each over three years to support research into early cancer detection.
 
Among the recipients are David Gorin at Harvard University, who is developing a new assay for the comparative analysis of protease activities in diseased and healthy tissues by “simultaneously investigating the activity of proteases on thousands of substrate peptides,” the Canary Foundation said in a statement.
 
Robert Sprung at the Vanderbilt-Ingram Cancer Center also was named a fellow. He is developing, standardizing, and applying a method for the proteomic analysis of formalin-fixed paraffin-embedded colon adema tissue.

The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge is weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.